These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2206278)

  • 1. Animal models for AIDS.
    Letvin NL
    Immunol Today; 1990 Sep; 11(9):322-6. PubMed ID: 2206278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunological manifestations and cytological characteristics of infection caused by the simian immunodeficiency virus (SIV) in rhesus monkeys].
    Persidskiĭ IuV; Shcherbinskaia AM; Barshteĭn IuA; Antonenko SV; Marichev IL
    Tsitol Genet; 1993; 27(6):97-104. PubMed ID: 8066812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of primate models for studying human immunodeficiency virus pathogenesis.
    Levy JA
    J Med Primatol; 1996 Jun; 25(3):163-74. PubMed ID: 8892037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of AIDS.
    Gardner MB; Luciw PA
    FASEB J; 1989 Dec; 3(14):2593-606. PubMed ID: 2556312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HIV-1 infection-related idiotype/clonotype (1F7) is expressed on antibodies directed to envelope glycoprotein in simian immunodeficiency virus- and chimeric simian/human immunodeficiency virus-infected rhesus monkeys.
    Müller S; Margolin DH; Min G
    Hybridoma; 1997 Feb; 16(1):17-21. PubMed ID: 9085123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.
    Putkonen P; Thorstensson R; Albert J; Hild K; Norrby E; Biberfeld P; Biberfeld G
    AIDS; 1990 Aug; 4(8):783-9. PubMed ID: 1979745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simian immunodeficiency virus: possible effects of deworming and tuberculin extrapolated to HIV/AIDS.
    Fincham JE; Adams VJ; Markus MB
    Vaccine; 2003 Jun; 21(19-20):2258-9. PubMed ID: 12744853
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protection against AIDS? The example of African monkeys].
    Jacquelin B; Rescanière O; Liovat AS; Petitjean G; Barré-Sinoussi F; Müller-Trutwin M
    Med Sci (Paris); 2010 May; 26(5):461-3. PubMed ID: 20510140
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.
    Zhou D; Shen Y; Chalifoux L; Lee-Parritz D; Simon M; Sehgal PK; Zheng L; Halloran M; Chen ZW
    J Immunol; 1999 Feb; 162(4):2204-16. PubMed ID: 9973496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
    Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immunity to HIV, SIV, and SHIV.
    Haigwood NL; Zolla-Pazner S
    AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonhuman primate models for HIV vaccine development.
    Letvin NL
    Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
    Gardner MB
    Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection.
    Geretti AM; Hulskotte E; Osterhaus AD
    J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818
    [No Abstract]   [Full Text] [Related]  

  • 17. Tackling HIV and AIDS: contributions by non-human primate models.
    Van Rompay KKA
    Lab Anim (NY); 2017 May; 46(6):259-270. PubMed ID: 28530684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simian immunodeficiency virus variants: threat of new lentiviruses.
    McClure HM; Novembre FJ
    Am J Med Sci; 1996 Jan; 311(1):30-3. PubMed ID: 8571984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus.
    Letvin NL; Schmitz JE; Jordan HL; Seth A; Hirsch VM; Reimann KA; Kuroda MJ
    Immunol Rev; 1999 Aug; 170():127-34. PubMed ID: 10566147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term non-progressive human immunodeficiency virus infection: new insights from the simian immunodeficiency virus model.
    Dittmer U; Hunsmann G
    J Gen Virol; 1997 May; 78 ( Pt 5)():979-84. PubMed ID: 9152413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.